Tech Company Financing Transactions

Ring Therapeutics Funding Round

Altitude Life Science Ventures, Flagship Pioneering and Invus participated in a $117 million Series B funding round for Ring Therapeutics. The round was announced on 7/29/2021.

Transaction Overview

Company Name
Announced On
7/29/2021
Transaction Type
Venture Equity
Amount
$117,000,000
Round
Series B
Proceeds Purpose
The company intends to use the funds for the continued development and expansion of its novel vector Anellogy platform.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
620 Memorial Dr. 300
Cambridge, MA 02139
USA
Phone
Undisclosed
Email Address
Overview
Powering a New Era of Gene Therapy. We are developing Anellovectors, the first potentially redosable and targetable gene therapy platform, by harnessing the human commensal virome.
Profile
Ring Therapeutics LinkedIn Company Profile
Social Media
Ring Therapeutics Company Twitter Account
Company News
Ring Therapeutics News
Facebook
Ring Therapeutics on Facebook
YouTube
Ring Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Tuyen Ong
  Tuyen Ong LinkedIn Profile  Tuyen Ong Twitter Account  Tuyen Ong News  Tuyen Ong on Facebook
Vice President
Simon Delagrave
  Simon Delagrave LinkedIn Profile  Simon Delagrave Twitter Account  Simon Delagrave News  Simon Delagrave on Facebook
VP - R & D
Roger Hajjar
  Roger Hajjar LinkedIn Profile  Roger Hajjar Twitter Account  Roger Hajjar News  Roger Hajjar on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/29/2021: Treeverse venture capital transaction
Next: 7/29/2021: Hightouch venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document funding rounds that are announced publicly. VC transactions reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary